rs200465752

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_020802.4(CEP126):​c.196A>T​(p.Ile66Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,612,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

CEP126
NM_020802.4 missense

Scores

1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.672
Variant links:
Genes affected
CEP126 (HGNC:29264): (centrosomal protein 126) Involved in cilium assembly; cytoplasmic microtubule organization; and mitotic spindle organization. Located in centrosome; ciliary base; and midbody. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04572463).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP126NM_020802.4 linkc.196A>T p.Ile66Leu missense_variant Exon 2 of 11 ENST00000263468.13 NP_065853.3 Q9P2H0
CEP126NM_001363543.2 linkc.-1084A>T 5_prime_UTR_variant Exon 2 of 12 NP_001350472.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP126ENST00000263468.13 linkc.196A>T p.Ile66Leu missense_variant Exon 2 of 11 1 NM_020802.4 ENSP00000263468.8 Q9P2H0
CEP126ENST00000670091.1 linkn.196A>T non_coding_transcript_exon_variant Exon 2 of 12 ENSP00000499679.1 A0A590UK33
CEP126ENST00000670318.1 linkn.196A>T non_coding_transcript_exon_variant Exon 2 of 12 ENSP00000499404.1 A0A590UJH0

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152246
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000112
AC:
28
AN:
251040
Hom.:
0
AF XY:
0.0000958
AC XY:
13
AN XY:
135726
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000657
AC:
96
AN:
1460704
Hom.:
0
Cov.:
29
AF XY:
0.0000674
AC XY:
49
AN XY:
726732
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000881
Gnomad4 NFE exome
AF:
0.0000423
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152246
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000941
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.0000824
AC:
10
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.196A>T (p.I66L) alteration is located in exon 2 (coding exon 2) of the CEP126 gene. This alteration results from a A to T substitution at nucleotide position 196, causing the isoleucine (I) at amino acid position 66 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
13
DANN
Benign
0.69
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.74
D
M_CAP
Benign
0.0020
T
MetaRNN
Benign
0.046
T
MetaSVM
Benign
-0.93
T
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.97
N
REVEL
Benign
0.066
Sift
Benign
0.25
T
Sift4G
Benign
0.65
T
Vest4
0.34
MutPred
0.16
Loss of methylation at K65 (P = 0.0823);
MVP
0.067
MPC
0.13
ClinPred
0.54
D
GERP RS
-2.8
gMVP
0.022

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200465752; hg19: chr11-101793439; API